March 11, 2005Current Opinion in Lipidology
Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia
Authors
Discussion
Loading...
Member takes
Implication
Recent findings uncover PCSK9’s role in cholesterol metabolism, linking it to autosomal dominant hypercholesterolemia.
Key Points
- This research aims to investigate the role of PCSK9 in cholesterol metabolism and its association with autosomal dominant hypercholesterolemia.
- Microarray studies and database searches identified PCSK9 as a novel gene implicated in cholesterol regulation.
- Clinical gene linkage studies were conducted in families diagnosed with autosomal dominant hypercholesterolemia without known genetic causes.
- PCSK9 missense mutations were linked to a specific form of autosomal dominant hypercholesterolemia identified as Hchola3.
- PCSK9 has been shown to regulate LDL receptor protein levels, influencing cholesterol metabolism.
Cite This Study
Maxwell et al. (2005) studied this question.